Skip to main content
Ligand Pharmaceuticals Incorporated (FRA:LGDN)
Germany flag Germany · Delayed Price · Currency is EUR
161.00
-4.00 (-2.42%)
At close: Dec 4, 2025

Ligand Pharmaceuticals Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
3,1281,9561,1271,0562,2701,307
Upgrade
Market Cap Growth
56.67%73.58%6.69%-53.48%73.60%-19.90%
Upgrade
Enterprise Value
2,9441,7519601,0492,2761,033
Upgrade
Last Close Price
157.00104.0064.5062.7693.8952.59
Upgrade
PE Ratio
75.54-23.88-45.18-
Upgrade
PS Ratio
14.6112.119.485.7510.699.78
Upgrade
PB Ratio
3.862.441.781.893.142.25
Upgrade
P/TBV Ratio
5.974.424.188.117.85-
Upgrade
P/FCF Ratio
119.3021.2627.048.9936.8631.90
Upgrade
P/OCF Ratio
114.9820.8625.128.1932.7629.30
Upgrade
EV/Sales Ratio
13.6310.848.085.7110.727.73
Upgrade
EV/EBITDA Ratio
59.8631.1122.9027.1122.0918.31
Upgrade
EV/EBIT Ratio
157.0578.73108.04369.1139.0730.77
Upgrade
EV/FCF Ratio
112.3019.0323.048.9336.9625.22
Upgrade
Debt / Equity Ratio
0.480.010.010.150.400.64
Upgrade
Debt / EBITDA Ratio
7.020.120.132.092.746.42
Upgrade
Debt / FCF Ratio
14.660.080.130.704.639.11
Upgrade
Asset Turnover
0.210.190.170.190.180.11
Upgrade
Inventory Turnover
6.741.711.884.383.504.20
Upgrade
Quick Ratio
23.668.0512.492.5010.394.70
Upgrade
Current Ratio
24.698.9314.152.6711.155.00
Upgrade
Return on Equity (ROE)
5.42%-0.53%8.29%-0.74%9.98%0.89%
Upgrade
Return on Assets (ROA)
1.48%1.66%0.79%0.18%3.11%1.80%
Upgrade
Return on Capital (ROIC)
1.60%1.86%0.88%0.21%3.58%1.99%
Upgrade
Return on Capital Employed (ROCE)
2.00%2.50%1.30%0.50%5.30%3.30%
Upgrade
Earnings Yield
1.32%-0.20%4.19%-2.96%2.21%-0.19%
Upgrade
FCF Yield
0.84%4.70%3.70%11.12%2.71%3.13%
Upgrade
Buyback Yield / Dilution
-6.20%-3.00%-5.27%2.19%-2.50%14.84%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.